In conclusion, we systematically elucidated the prognostic value of PPAR signaling pathway-related genes in patients with HCC and established a prognostic model comprising a four-gene signature (G6PD, SLC10A1, ABCC1 and PKIB). This evidence concerns the gene G6PD and hepatocellular carcinoma.